| Literature DB >> 30456966 |
Hlolisile W Chiya1, Joanne R Naidoo, Busisiwe P Ncama.
Abstract
BACKGROUND: South Africa's prevention of mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV) programme has undergone rapid changes in the last two decades. Initially, the provision of single antiretroviral therapy was based on eligibility criteria in the year 2001, which later changed to combination therapy. This was aimed at preventing mother-to-child transmission of HIV. Since 2015, all pregnant women were eligible for antiretroviral treatment regardless of their CD4 count. Although significant strides were made to reduce mother-to-child transmission of HIV, increased efforts are required to meet UNAIDS targets, World Health Organization (WHO) elimination framework goals and sustainable development goals to eliminate new HIV infections in children and ending the HIV epidemic by 2030. AIM: The aim of the study was to explore healthcare workers' experiences and patient perceptions of the implementation of rapid changes to the PMTCT programme in four public healthcare facilities.Entities:
Keywords: PMTCT program; changes; health care workers; implementation
Mesh:
Substances:
Year: 2018 PMID: 30456966 PMCID: PMC6244065 DOI: 10.4102/phcfm.v10i1.1788
Source DB: PubMed Journal: Afr J Prim Health Care Fam Med ISSN: 2071-2928
Demographic details of participants.
| Variable | Health workers | Community caregivers | Pregnant women | % | Total |
|---|---|---|---|---|---|
| 18–24 | 3 | 0 | 21 | 39 | 24 |
| 25–31 | 6 | 0 | 9 | 25 | 15 |
| 32–38 | 7 | 1 | 8 | 26 | 16 |
| 39–45 | 3 | 1 | 2 | 10 | 6 |
| Total | 19 | 2 | 40 | 100 | 61 |
| Single | 11 | 1 | 24 | 59 | 36 |
| Married | 7 | 1 | 16 | 39 | 24 |
| Widowed | 1 | 0 | 0 | 2 | 1 |
| Total | 19 | 2 | 40 | 100 | 61 |
| No education | 0 | 0 | 0 | - | 0 |
| Primary education | 0 | 0 | 7 | 11 | 7 |
| Secondary education | 0 | 0 | 17 | 28 | 17 |
| Higher education | 4 | 2 | 12 | 30 | 18 |
| Diploma or degree | 15 | 0 | 4 | 31 | 19 |
| Total | 19 | 2 | 40 | 100 | 61 |
Evolution of the programme for prevention of mother-to-child transmission in South Africa.
| Year | PMTCT programme interventions |
|---|---|
| 1998–1999 | PMTCT programme started in two sites in Khayelitsha, Western Cape despite national policy. |
| 2000 | 13th International HIV Conference in Durban, KZN. Data were presented which highlighted the effectiveness of antiretroviral regimen to reduce mother-to-child transmission of HIV. |
| 2001 | Two research sites established by NDOH in each province for 2-year period as pilot sites, to understand the operational challenges of introducing antiretroviral therapy in pregnancy for PMTCT. |
| 2001 | Court challenge to pilot programme lead by TAC, representing civil society. December 2001: SA government ordered by the court to develop an effective national programme to reduce MTCT by 2002. |
| 2002 | Government unsuccessful in appealing the court decision, as a result of which the PMTCT programme commences. |
| 2003 | New operational plan introduced for treating HIV-positive people. Nevirapine programme introduced; treatment extended to all pregnant women and children infected with HIV, with related healthcare services such as voluntary counselling and testing. |
| 2004 | Comprehensive care management and treatment of HIV-infected individuals. Pregnant women with CD4 count less than 200 cells/mm3 eligible for highly active antiretroviral treatment (HAART). |
| 2008 | DOH update of PMTCT policy to include dual therapy with azidothymidine and NVP from 28 weeks’ gestation, nevirapine treatment for pregnant women during labour and for their babies within 72 h of delivery, and HAART for pregnant women with CD4 cell count less than 200 cells/mm3. |
| 2008 | Launch of the national PMTCT accelerated plan (9A-Plan) aimed at reduction of MTCT from 12% in 2008 to less than 5% by 2011 in line with National Strategic Plan (2007–2011). |
| 2009 | President Zuma’s speech on World AIDS Day (1 December each year) outlines changes to be implemented in 2010 to demonstrate political leadership in the fight against HIV. |
| 2010 | DOH revises the PMTCT policy to include lifelong HAART for HIV-positive women with CD4 count less than 350 cells/mm3 and dual ART from 14 weeks onwards for pregnant women with CD4 above 350 cells/mm3 (Option A of WHO); all infants to take NVP daily for 6 weeks and to continue for all breastfeeding infants whose mothers were on HAART, for postnatal transmission reduction. |
| 2011 | Phasing out of free formula following a national conference on breastfeeding; Minister of Health endorses a breastfeeding policy where breastfeeding to be used exclusively at public health facilities, with formula milk reserved for medical indications. |
| 2011 | In line with global agencies, DOH develops a national action framework for eliminating MTCT of HIV. |
| 2013 | Revised guidelines to include fixed-dose combination (FDC), Option B, according to new WHO recommendations; the routine offers of ART irrespective of CD4 count or clinical stage will improve treatment access; simplified approaches, including a common regimen of tenofovir, lamivudine or emtricitabine and efavirenz as a FDC tablet for women and older children living with HIV, should also improve uptake. |
| 2015 | Revised ART guidelines. Government announces (in budget speech by Dr Motsoaledion in July 2014) that South Africa will adopt an Option B+ as per WHO recommendations; this allows all HIV-positive pregnant women to be started on ART for lifelong therapy regardless of their CD4 count; women who are breastfeeding and women who are within 1 year post-partum to be initiated to eliminate MTCT; guidelines effective from 1 January 2015. |
| 2016 Sept 1 | Universal testing and treating implemented. All HIV-tested positive population regardless of pregnancy, or post-partum, or their CD4 count are eligible to be initiated on lifelong ART. |
Source: Barron P, Pilly Y, Doherty T, et al. Eliminating mother-to-child transmission in South Africa. https://doi.org/10.2471/BLT.12.106807
KZN, KwaZulu-Natal; ART, antiretroviral treatment; PMTCT, prevention of mother-to-child transmission of HIV; MTCT, mother-to-child transmission of HIV; FDC, fixed-dose combination; WHO, World Health Organization; NDOH, National Department of Health; DOH, Department of Health; NVP, nevirapine; TAC, Treatment Action Campaign.
Data collection summary.
| Participants and/or key informants | Method of data collection | Sampling criteria | Number sampled ( |
|---|---|---|---|
| Healthcare workers incl. CCGs | Focus group discussions | Purposive sampling | 21 |
| Pregnant women | Semi-structured in-depth interviews | Purposive sampling | 40 |
CCGs, community care givers, which in this study refers to the care givers that work in defined communities to provide households with basic health needs.
The experience of health workers who were interviewed during focus group discussion.
| Variables ( | Total number |
|---|---|
| Advanced HIV and/or AIDS management training | 1 |
| Advanced midwifery | 3 |
| More than 10 years’ experience | 7 |
| Less than 10 years’ experience but more than 5 years | 8 |
| Degree and/or diploma | 15 |
FIGURE 1Sample of key questions.